P-0222 Salvage Panitumumab in Kras Wild-Type Metastatic Colorectal Cancer Patients Without Progression on Prior Cetuximab-Based Regimens: A Multicenter, Matched-Pair, Case-Control Study

Cancer Patients ◽

Case Control Study ◽

Case Control ◽

Matched Pair ◽

Wild Type ◽

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case–control study

Annals of Oncology ◽

10.1093/annonc/mdx546 ◽

2017 ◽

Vol 28 (12) ◽

pp. 3009-3014 ◽

Cited By ~ 36

Author(s):

C. Cremolini ◽

F. Morano ◽

R. Moretto ◽

R. Berenato ◽

E. Tamborini ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Cancer Patients ◽

Case Control Study ◽

Case Control ◽

Control Study ◽

Selection Of

Dietary Intake and Serum Levels Status of Folate and Vitamin B12 among Jordanian Colorectal Cancer Patients: a case‐control study

The FASEB Journal ◽

10.1096/fasebj.25.1_supplement.978.5 ◽

2011 ◽

Vol 25 (S1) ◽

Author(s):

Mostafa I Waly ◽

Mostafa A Arafa ◽

Sahar B Jriesat ◽

Ahmed M AlKhafajei ◽

Sunny A Sallam

Keyword(s):

Colorectal Cancer ◽

Dietary Intake ◽

Vitamin B12 ◽

Cancer Patients ◽

Case Control Study ◽

Serum Levels ◽

Case Control ◽

Folate And Vitamin B12 ◽

Survival Rate and Prognostic Factors in Perforated Colorectal Cancer Patients: A Case-Control Study

Journal of the Korean Society of Coloproctology ◽

10.3393/jksc.2010.26.1.69 ◽

2010 ◽

Vol 26 (1) ◽

pp. 69 ◽

Cited By ~ 5

Author(s):

Min Sang Kim ◽

Seung Woo Lim ◽

Sung Jin Park ◽

Geumhee Gwak ◽

Keun Ho Yang ◽

...

Keyword(s):

Colorectal Cancer ◽

Prognostic Factors ◽

Survival Rate ◽

Cancer Patients ◽

Case Control Study ◽

Case Control ◽

Perforated Colorectal Cancer ◽

Clinicians’ attitude to doublet plus anti-EGFR versus triplet plus bevacizumab as first line treatment in left-sided RAS and BRAF wild-type metastatic colorectal cancer patients: a multicentre, “real-life”, case-control study

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.07.003 ◽

2021 ◽

Author(s):

Alessandro Parisi ◽

Giampiero Porzio ◽

Katia Cannita ◽

Olga Venditti ◽

Antonio Avallone ◽

...

Keyword(s):

Colorectal Cancer ◽

Case Control Study ◽

Real Life ◽

Case Control ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

Control Study ◽

First Line Treatment

Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resection

European Journal of Cancer ◽

10.1016/j.ejca.2016.02.003 ◽

2016 ◽

Vol 59 ◽

pp. 13-21 ◽

Cited By ~ 24

Author(s):

Jannemarie A.M. de Ridder ◽

Eric P. van der Stok ◽

Leonie J. Mekenkamp ◽

Bastiaan Wiering ◽

Miriam Koopman ◽

...

Keyword(s):

Colorectal Cancer ◽

Liver Resection ◽

Liver Metastases ◽

Cancer Patients ◽

Systemic Therapy ◽

Case Control Study ◽

Case Control ◽

Retrospective Case ◽

6054 Management of isolated non-resectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71149-8 ◽

2009 ◽

Vol 7 (2) ◽

pp. 337-338 ◽

Cited By ~ 1

Author(s):

L.B.J. Valkenburg-van Iersel ◽

M. Koopman ◽

C.J.H. van de Velde ◽

L. Mol ◽

P.J.K. Kuppen ◽

...

Keyword(s):

Colorectal Cancer ◽

Liver Metastases ◽

Cancer Patients ◽

Systemic Chemotherapy ◽

Case Control Study ◽

Case Control ◽

Hepatic Perfusion ◽

Isolated Hepatic Perfusion ◽

Clinicopathological Features of Colorectal Cancer Patients Under the Age of 50: Recent Experience and Case-Control Study of Prognosis in a Japanese Cohort

Digestion ◽

10.1159/000446344 ◽

2016 ◽

Vol 93 (4) ◽

pp. 272-279 ◽

Cited By ~ 5

Author(s):

Yuzo Nagai ◽

Keisuke Hata ◽

Kazushige Kawai ◽

Koji Murono ◽

Koji Yasuda ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Case Control Study ◽

Case Control ◽

Clinicopathological Features ◽

Recent Experience ◽

Japanese Cohort ◽

Management of isolated nonresectable liver metastases in colorectal cancer patients: a case–control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdp589 ◽

2010 ◽

Vol 21 (8) ◽

pp. 1662-1667 ◽

Cited By ~ 17

Author(s):

L.B.J. van Iersel ◽

M. Koopman ◽

C.J.H. van de Velde ◽

L. Mol ◽

E.L. van Persijn van Meerten ◽

...

Keyword(s):

Colorectal Cancer ◽

Liver Metastases ◽

Cancer Patients ◽

Systemic Chemotherapy ◽

Case Control Study ◽

Case Control ◽

Hepatic Perfusion ◽

Isolated Hepatic Perfusion ◽

Abstract 2619: Genetic landscape of KRAS-NRAS-BRAF-PIK3CA wild type metastatic colorectal cancer patients enrolled in the CAPRI clinical trial

10.1158/1538-7445.am2018-2619 ◽

2018 ◽

Cited By ~ 1

Author(s):

Anna Maria Rachiglio ◽

Matilde Lambiase ◽

Francesca Fenizia ◽

Alessia Iannaccone ◽

Cristin Roma ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Wild Type ◽

Genetic Landscape ◽

Colorectal Cancer Patients

FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial

Annals of Oncology ◽

10.1093/annonc/mdz155.088 ◽

2019 ◽

Vol 30 ◽

pp. iv23-iv24 ◽

Cited By ~ 3

Author(s):

A. Fernández Montes ◽

N. Martinez Lago ◽

J. De la Cámara Gómez ◽

M. Covela Rúa ◽

A. Cousillas Castiñeiras ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Treatment Phase ◽

Line Treatment ◽

Second Line ◽

Wild Type ◽

First Line ◽

Colorectal Cancer Patients